Zuprevo – Rx 250 mL
Zuprevo 180 mg/ml is licensed for the treatment and prevention of bovine respiratory disease (BRD) associated with M. haemolytica, P. multocida and H.somni sensitive to tildipirosin. Zuprevo contains the active tildipirosin – a 16-membered tribasic macrolide antibiotic unique to MSD Animal Health. Zuprevo offers real world benefits – the 180 mg/ml easily syringed solution for injection specifically developed for cattle, delivers a fast and long acting macrolide in a small dose volume. For the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating dairy cattle, and for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni.
Zuprevo – Rx 250 mL Highlights:
- SKU: 17455
- Manufacturer: Merck Animal Health
- Administer 4 mg tildipirosin/kg body weight (equivalent to 1 ml/45 kg body weight) once only
- For treatment of cattle over 450 kg body weight, divide the dose so that no more than 10 ml are injected at one site










